Back

The clinical prognosis of elderly patients with decompensated congestive heart failure greatly improved for 7 years after introduction of our unique clinical pathway

28 August 2023 (14:15 - 14:50)
Organised by: Logo
Congress Presentation Part of: Effects and treatment of comorbidities in acute heart failure Multidisciplinary Interventions ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Toyohiro Endo

Mitoyo General Hospital, Kanonji (Japan)

5 More presentations in this session

Presentation thumbnail
Impact of systemic lupus erythematosus on outcomes in patients hospitalized with acute decompensated heart failure with reduced and preserved ejection fraction: a national inpatient sample study (2016
Doctor S. Nomigolzar (Greenville, US)
Abstract Slides Video
Presentation thumbnail
Cardiac resynchronosation and left ventricular ejection fraction improvement with single ventricular conduction pacing system lead
Mr F. Ayala Valani (Sherbrooke, CA)
Abstract Slides Video
Presentation thumbnail
Deep night: critical periods for the onset of acute myocardial infarction in obstructive sleep apnea patients
Doctor Y. Wang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Disproportionate MR and 5-year mortality following acute heart failure hospitalisation
Doctor M. Berrill (London, GB)
Abstract Slides Video
Presentation thumbnail
Outcome of transcatheter mitral valve repair in heart failure patients with reduced ejection fraction and severe left ventricular dilatation
Doctor M. Sone (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Effects and treatment of comorbidities in acute heart failure

The Event

Event poster

ESC Congress 2023

28 August 2023 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Examination of the usefulness of our original clinical pathway for acute care of congestive heart failure aiming to improve short and long-term clinical prognosis
thumbnail
Congress Presentation
Examination about clinical efficacy and safety of active use of tolvaptan for decompensated congestive heart failure cases
thumbnail
Congress Presentation
How has the systematization of comprehensive care avoided hospitalisation for heart failure?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources